Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Five New Swine Flu Cases Bring UK Total To 117
According to the Health Protection Agency (HPA), UK, there were five new confirmed cases of swine flu (H1N1), bringing the total to 117. The HPA"s laboratories carry out all testing of swine flu virus. The five new cases include two adults from London, two adults from South East England, and a child from the West Midlands. Two of them returned from a country where swine flu exists, while another is linked to a previously confirmed case in England - the s of the other two are still being investigated, the HPA reported. Nobody in the UK has died from swine flu.

Moving To The U.S. Increases Cancer Risk For Hispanics
Results of a new study confirm trends that different Hispanic population groups have higher incidence rates of certain cancers and worse cancer outcomes if they live in the United States, than they do if they live in their homelands.
News of the day
Prostate Cancer Screening Has Yet To Prove Its Worth
The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report in CA: A Cancer Journal for Clinicians. Authored by Otis W. Brawley, M.D. of the American Cancer Society and Donna Ankerst, Ph.D. and Ian M. Thompson, M.D. of the University of Texas Health Science Center at San Antonio, the review says because prostate cancer is virtually ubiquitous in men as they age, it is clear that a goal of "finding more cancers" is not acceptable. Instead, public health principles demand that screening must reduce the risk of death from prostate cancer, reduce the suffering from prostate cancer, or reduce health care costs when compared with a non-screening scenario. The authors suggest prostate cancer screening has yet to reach one of these standards to date.
Mental Health

Vaccine Maker To Give 100 Million Swine Flu Shots To WHO

Sanofi-aventis, a French global healthcare company that makes vaccines announced on Wednesday that it will be giving the World Health Organization (WHO) 100 million doses of vaccine for H1N1 swine flu so it can distribute them to the countries that most need them. Sanofi-aventis Chief Executive Officer Christopher A Viehbacher told the opening session of the Pacific Health Summit in Seattle, Washington that he wanted to back WHO Director General"s call for common action. "Exceptional times require exceptional responses. We need to act responsibly and we all have to play our part," said Viehbacher. "That is the reason why we intend to donate 100 million doses of influenza vaccine to the World Health Organization (WHO) to help developing countries face the influenza pandemic," he added. Although the WHO says it has now received reports of nearly 40,000 worldwide lab-confirmed cases of novel A(H1N1) swine flu, including 167 deaths, and has raised the status level to phase 6, indicating global pandemic, the organization has not yet said anything about who should get vaccinated. Also, because this strain has not infected people before, it is not clear if one or two doses will be needed to achieve full immunization. Vaccine producers are just coming to the end of producing seasonal flu vaccine, after which they will start making vaccine against the new swine flu virus. It will be several weeks before the first batches are ready, which is probably too late for countries in the southern hemisphere who are about to enter the height of their annual flu season. Swine flu is now reaching southern countries that have not reported cases before. Earlier today South Africa joined the list, with a new case of swine flu in a 12-year old boy recently returned from the US. WHO estimate world capacity to produce swine flu vaccine is about 4.9 billion, which is not enough to vaccinate a world population of 6.5 billion, and if two shots are needed, then it will barely reach half that number. Viehbacher said that sanofi-aventis will reserve 10 per cent of its swine flu vaccine for the WHO to help developing countries fight the pandemic. Over and above the 100 million doses it will donate, the company will offer additional doses at discounted prices to developing countries, depending on production capacity, reported the Associated Press. British drugmaker GlaxoSmithKline said they will do the same, and have offered to donate 50 million doses of swine flu vaccine for the WHO to distribute to developing countries. They said last week that they would be ready to start large scale production within weeks. According to the AP report, Novartis, another major vaccine maker based in Switzerland have decided not to go down the donation route. Company spokesman Eric Althoff said on Wednesday that the company would prefer to find a more sustainable way to support developing countries than one time donations. They are considering selling vaccines at discounted prices instead, he said. s: Sanofi Aventis, AP. Written by: Catharine Paddock, PhD Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009